Builds upon NCQA Accreditation for its Care Management Programs
Geneia, a healthcare analytics and technology leader, has achieved National Committee on Quality Assurance (NCQA)-certification for two measures, Diabetes: Hemoglobin A1c Poor Control and Breast Cancer Screening, for electronic clinical quality measures (eCQM) released January 2017 for the Theon® advanced analytics and insights platform. The certification builds upon the company's commitment to validation of its clinical programs and advanced analytics solution. In 2016, Geneia was awarded full, three-year NCQA Case Management Accreditation and Patient and Practitioner Oriented Disease Management Accreditation for its asthma, coronary artery disease, heart failure, chronic obstructive pulmonary disease and diabetes programs (https://www.geneia.com/news-events/press-releases/2016/august/geneia-awarded-ncqa-accreditation-for-its-care-management-programs). ... |